The study demonstrates that rebinding, diffusion, and circulation removal are primary mechanisms for terminating noradrenaline action in skeletal muscle, with liberated noradrenaline reducing transcapillary transport to prolong its effect.
Answers are grounded in this paper and cite their sources.
Animal data on noradrenaline termination mechanisms warrant no clinical change; leaves open translation to human sympathetic regulation.
The vascular bed of dog musculus gracilis in situ was perfused with blood at a constant flow rate. Infused H3-noradrenaline was retained and then released spontaneously at a slow rate. The major fraction of released radioactivity has been identified as normetanephrine, 3-methoxy-4-hydroxymandelic acid, and 3-methoxy-4-hydroxyphenylglycol. Upon vasomotor nerve stimulation, there was a concomitant reduction in outflow of total radioactivity and in noradrenaline metabolites and delayed elevation of noradrenaline outflow. After cessation of the stimulus, return of peripheral resistance and decline in noradrenaline outflow were parallel. Vasomotor nerve stimulation after pretreatment with phenoxybenzamine resulted in an immediate and larger increase in noradrenaline outflow. Vasomotor nerve stimulation did not induce any net change in the outflow of metabolic products. Rebinding of liberated noradrenaline and diffusion and removal by the circulation appear to be the major mechanisms for ending the action of noradrenaline. Transcapillary transport is reduced by the liberated noradrenaline and this serves to prolong the action of the neurohumor.
No takes yet. Share an insight, caveat, or question.
Rosell et al. (1963) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: